Ovagen (Glu-Asp-Leu) is a synthetic tripeptide from the Khavinson bioregulator series designed to normalize liver and gastrointestinal function through tissue-specific gene regulation.
1 independent Janoshik purity test cover Ovagen across 1 vendor.
Category: Bioregulator / Research. Evidence rating: D (animal/preclinical only).
Clinical status: Research-only
Modulates hepatocyte gene expression and liver protein synthesis normalization through epigenetic regulation at tissue-specific loci. Supports GI epithelial function.
Safety considerations: Minimal reported side effects in Russian literature.
Reviewed by the PeptideAtlas Editorial Team.
| Production method | synthetic |
|---|---|
| Anti-doping status | not-listed |
| Vendor | Best tested purity |
|---|---|
| Peptide Gurus | 99.2% |
Related peptides: Cartalax.
Ovagen is a Khavinson bioregulator tripeptide researched for liver and gastrointestinal tissue support, particularly hepatic cell function and GI mucosal health.
OVAGEN has been studied for: Liver tissue support, GI mucosal health, Hepatic function, Digestive tissue repair. Khavinson bioregulator; liver and GI tissue focus.
Short peptide bioregulator that may modulate gene expression in hepatocytes and GI epithelial cells, supporting tissue maintenance and metabolic function.